EUVIMEDEUVIMED entdecken
Open Access

ReMeDy : A Flexible Statistical Framework for Region‐Based Detection of DNA Methylation Dysregulation

Suvo Chatterjee iD, Siddhant Meshram iD, Ganesan Arunkumar iD, Fasil Tekola-Ayele, Arindam Fadikar iD

Statistics in Medicine · 2026

DOI: 10.1002/sim.70716 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, 2026. Verfasst von Suvo Chatterjee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Indiana University, Bloomington, Indiana, USA. Hauptthemen laut MEDLINE: DNA Methylation. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: faculty start-up funds from School of Public Health-Bloomington, Indiana University, Lilly Endowment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Region‐based epigenome‐wide association studies have demonstrated improved statistical power and biological interpretability compared with probe‐wise analyses of DNA methylation data. However, most existing region‐based methods characterize methylation dysregulation primarily through changes in mean methylation levels associated with a phenotype of interest. Substantial evidence indicates that phenotype‐associated methylation alterations may also manifest through changes in methylation variability or through joint shifts in mean and variability. Despite this, no existing statistical framework jointly models mean–variance methylation changes in a region‐based manner. We propose ReMeDy, a flexible statistical framework that uses a hierarchical likelihood approach within a generalized linear model setting to identify differentially methylated regions, variably methylated regions, and regions exhibiting joint differential and variable methylation at a genome‐wide scale. Unlike existing models, ReMeDy operates directly on biologically defined co‐methylated regions, allowing it to naturally capture spatial correlation inherent in DNA methylation array data, while avoiding reliance on heuristic, user‐defined tuning parameters such as smoothing spans and kernel bandwidths that can substantially influence results and introduce subjectivity. Through extensive simulation studies and comprehensive benchmarking against popular models, we demonstrate that ReMeDy maintains false discovery and Type‐I error rates at nominal levels while achieving consistently higher statistical power across a wide range of realistic scenarios. Application to population‐level DNA methylation data further shows that ReMeDy identifies biologically meaningful regions and pathways implicated in complex human diseases that are not captured by conventional mean‐based analyses alone. ReMeDy is implemented as an open‐source R package and is freely available at https://github.com/SChatLab/ReMeDy .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationHumansComputer SimulationGenome-Wide Association StudyLikelihood FunctionsLinear ModelsModels, Statistical

Stichwörter der Autor:innen

DNA methylationdifferential methylationepigenome‐wide association studiesmethylation dysregulationregion‐based analysesvariable methylation

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, Indiana University, Bloomington, Indiana, USA.
  • Department of Cell Biology and Physiology, University of New Mexico, Albuquerque, New Mexico, USA.
  • Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
  • Decision and Infrastructure Sciences Division, Argonne National Laboratory, Lemont, Illinois, USA.
  • Consortium for Advanced Science and Engineering, University of Chicago, Chicago, Illinois, USA.

ORCID-Profile: Suvo Chatterjee, Siddhant Meshram, Ganesan Arunkumar, Arindam Fadikar

Förderung

  • faculty start-up funds from School of Public Health-Bloomington, Indiana University
  • Lilly Endowment

Zitieren

APA

Chatterjee, S., Meshram, S., Arunkumar, G., Tekola-Ayele, F., & Fadikar, A. (2026). ReMeDy : A Flexible Statistical Framework for Region‐Based Detection of DNA Methylation Dysregulation. Statistics in Medicine. https://doi.org/10.1002/sim.70716

Vancouver

Chatterjee S, Meshram S, Arunkumar G, Tekola-Ayele F, Fadikar A. ReMeDy : A Flexible Statistical Framework for Region‐Based Detection of DNA Methylation Dysregulation. Statistics in Medicine. 2026. doi:10.1002/sim.70716

BibTeX
@article{Chatterjee2026,
  author = {Chatterjee, Suvo and Meshram, Siddhant and Arunkumar, Ganesan and Tekola-Ayele, Fasil and Fadikar, Arindam},
  title = {ReMeDy : A Flexible Statistical Framework for Region‐Based Detection of DNA Methylation Dysregulation},
  journal = {Statistics in Medicine},
  year = {2026},
  doi = {10.1002/sim.70716}
}
Kostenlos starten →